Evogene Ltd. (EVGN)
NASDAQ: EVGN
· Real-Time Price · USD
1.32
-0.04 (-2.94%)
At close: Aug 15, 2025, 11:18 AM
-2.94% (1D)
| Bid | 1.28 |
| Market Cap | 11.5M |
| Revenue (ttm) | 6.76M |
| Net Income (ttm) | -15.21M |
| EPS (ttm) | -2.51 |
| PE Ratio (ttm) | -0.53 |
| Forward PE | -0.78 |
| Analyst | Buy |
| Ask | 1.35 |
| Volume | 16,612 |
| Avg. Volume (20D) | 1,850,748 |
| Open | 1.32 |
| Previous Close | 1.36 |
| Day's Range | 1.30 - 1.35 |
| 52-Week Range | 0.95 - 4.18 |
| Beta | 1.42 |
About EVGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EVGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Evogene Ltd. is scheduled to release its earnings on
Aug 19, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+30.93%
Evogene shares are trading higher after the compan...
Unlock content with
Pro Subscription
10 months ago
+19.92%
Evogene shares are trading higher after the company announced its subsidiary received a grant from the Israel Innovation Authority to advance its program to develop a technology for the delivery of Ag-biologicals to agriculture.
